drugset
drugset / Trial / NCT01806415

Pharmacokinetics and Side Effects of the mGlu5 Antagonist Fenobam in Adult Healthy Volunteers

NCT01806415 ↗

Phase 1 Completed 32 enrolled Washington University School of Medicine
RandomizedParallel-groupTriple-blind

Summary

This is a randomized, blinded, parallel group, placebo-controlled trial on 32 evaluable healthy male and non-pregnant female, 18-50 year old volunteers. The investigators goal is to observe the pharmacokinetics of fenobam after oral administration of 50, 100 or 150 mg in groups of healthy individuals and to compare the side effects and tolerability of a single dose of fenobam with placebo.

Timeline

Start
2013-05
Primary completion
2014-03
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject FENOBAM ANHYDROUS Small molecule 50 mg Oral
Subject FENOBAM ANHYDROUS Small molecule 100 mg Oral
Subject FENOBAM ANHYDROUS Small molecule 150 mg Oral

Indications

No indication recorded.